SpyGlass Pharma (SGP) Research & Development (2025 - 2026)

SpyGlass Pharma (SGP) Research & Development (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 993.80 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.63 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.37 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 394.92 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 612.28 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 1,146.05
7 Royalty Pharma 33.72 Bn 35.84 Bn - 97.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 413.13 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 210.03 Mn
10 SpyGlass Pharma 876.29 Mn 876.29 Mn - 10.94 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 10.94 Mn
Jun 30, 2025 7.33 Mn